Biotech Stock Roundup: KaloBios Soars as Shkreli Steps In, FDA Panel Not Convinced about BioMarin Dr
Biotech Stock Roundup: KaloBios Soars as Shkreli Steps In, FDA Panel Not Convinced about BioMarin Drug
3 Biotech Stocks to Buy in December
Are you interested in putting a few biotech stocks on your holiday wish list? Our contributors think you should give these three names a look.
Vertex Pharmaceuticals Incorporated Moved 16% Higher in October -- Here's Why
A great-looking third-quarter report sends shares of the cystic fibrosis leader higher.
5 Drugs That Are the Face of Prescription Drug Reform
Congress is cracking down on rising prescription drug costs, and these five therapies could prove to be the face of that reform.